These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6959521)

  • 1. Dysphoric phenomena associated with haloperidol treatment of Tourette syndrome.
    Bruun RD
    Adv Neurol; 1982; 35():433-6. PubMed ID: 6959521
    [No Abstract]   [Full Text] [Related]  

  • 2. Haloperidol-induced dysphoria in patients with Tourette syndrome.
    Caine ED; Polinsky RJ
    Am J Psychiatry; 1979 Sep; 136(9):1216-7. PubMed ID: 289300
    [No Abstract]   [Full Text] [Related]  

  • 3. Causes of haloperidol discontinuation in patients with Tourette's disorder: management and alternatives.
    Silva RR; Muñoz DM; Daniel W; Barickman J; Friedhoff AJ
    J Clin Psychiatry; 1996 Mar; 57(3):129-35. PubMed ID: 8617698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Withdrawal akathisia: case reports and a proposed classification of chronic akathisia.
    Lang AE
    Mov Disord; 1994 Mar; 9(2):188-92. PubMed ID: 8196681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral effects of haloperidol in young Tourette syndrome patients.
    Bogomolny A; Erenberg G; Rothner AD
    Adv Neurol; 1982; 35():427-32. PubMed ID: 6959520
    [No Abstract]   [Full Text] [Related]  

  • 6. Haloperidol.
    Med Lett Drugs Ther; 1967 Sep; 9(18):70-1. PubMed ID: 5233811
    [No Abstract]   [Full Text] [Related]  

  • 7. New pharmacological approaches in the treatment of Tourette syndrome.
    Borison RL; Ang L; Chang S; Dysken M; Comaty JE; Davis JM
    Adv Neurol; 1982; 35():377-82. PubMed ID: 6756088
    [No Abstract]   [Full Text] [Related]  

  • 8. Tardive dyskinesia and chronic neuroleptic treatment of Tourette patients.
    Shapiro E; Shapiro AK
    Adv Neurol; 1982; 35():413. PubMed ID: 6959518
    [No Abstract]   [Full Text] [Related]  

  • 9. Amantadine in Tourette syndrome.
    Borison RL; Davis JM
    Curr Psychiatr Ther; 1983; 22():127-30. PubMed ID: 6587960
    [No Abstract]   [Full Text] [Related]  

  • 10. The pharmacotherapy of Tourette syndrome.
    Caine ED
    Int J Neurol; 1980; 14(1):123-6. PubMed ID: 6959970
    [No Abstract]   [Full Text] [Related]  

  • 11. [Nicotine in neuropsychiatric movement disorders].
    Erdmann R
    Fortschr Neurol Psychiatr; 1996 Sep; 64(9):362-6. PubMed ID: 8991874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of Gilles de la Tourette Syndrome with haloperidol and clonidine].
    Fennig S; Bauer A; Kronnenberg Y
    Harefuah; 1984 May; 106(10):457-8. PubMed ID: 6590432
    [No Abstract]   [Full Text] [Related]  

  • 13. [Two cases of tardive Tourette syndrome].
    Yamauchi K; Ohmori T
    Seishin Shinkeigaku Zasshi; 2006; 108(5):459-65. PubMed ID: 16869393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treating Tourette syndrome with haloperidol: predictors of success.
    Schwabe MJ; Konkol RJ
    Wis Med J; 1989 Oct; 88(10):23-7. PubMed ID: 2815810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tourette syndrome associated with mental retardation: a single-subject treatment study with haloperidol.
    Rosenquist PB; Bodfish JW; Thompson R
    Am J Ment Retard; 1997 Mar; 101(5):497-504. PubMed ID: 9083606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Tourette's syndrome with haloperidol, review of 34 cases.
    Shapiro AK; Shapiro E; Wayne H
    Arch Gen Psychiatry; 1973 Jan; 28(1):92-7. PubMed ID: 4509400
    [No Abstract]   [Full Text] [Related]  

  • 17. Clonidine treatment of Tourette syndrome.
    Bruun RD
    Adv Neurol; 1982; 35():403-5. PubMed ID: 6959516
    [No Abstract]   [Full Text] [Related]  

  • 18. Prolactin monitoring of haloperidol and pimozide treatment in children with Tourette's syndrome.
    Sallee FR; Dougherty D; Sethuraman G; Vrindavanam N
    Biol Psychiatry; 1996 Nov; 40(10):1044-50. PubMed ID: 8915564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Gilles de la Tourette syndrome with depot neuroleptics.
    Paolucci S; Buttinelli C; Fiume S; Ciani S; Lenzi GL
    Acta Neurol (Napoli); 1984 Jun; 6(3):222-4. PubMed ID: 6591768
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical efficacy of haloperidol, pimozide, penfluridol, and clonidine in the treatment of tourette syndrome.
    Shapiro AK; Shapiro E
    Adv Neurol; 1982; 35():383-6. PubMed ID: 6959514
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.